Industry is nervous about strengthening quarantine guideline

A ban on year-end events

Private gatherings in the Seoul metropolitan area are limited to 6 people.

 

With COVID-19 (step-by-step daily recovery) was suspended after a month of implementation due to the re-proliferation of COVID-19.

 

The pharmaceutical bio industry is also nervous about the worsening COVID-19 situation.

 

On the 6th, the government tightened quarantine guidelines again by reducing the limit on the number of private gatherings to six in the metropolitan area and eight in the non-metropolitan area.

 

In fact, it is the suspension of With Corona.

 

The strengthened quarantine guidelines will be applied until the 2nd of next month.

 

The period can be adjusted depending on the trend situation.

 

The pharmaceutical bio industry has also strengthened internal guidelines in line with these measures.

 

In particular, it is recommended to refrain from public gatherings, including informal private gatherings, as the end of the year is approaching.

 

Yuhan Corporation again urged executives and employees to conduct remind-level retraining and comply with personal quarantine rules.

 

The company's rule is to wear a mask at all times while working and refrain from multi-use facilities and private gatherings.

 

End-of-the-year events such as workshops will be refrained from as much as possible and will be held non-face-to-face only if inevitable.

 

Efforts are also made to minimize contact within the company.

 

The time to use the cafeteria is set differently for each department, and lunch boxes are provided to some.

 

Last month, Yuhan Corporation changed its guidelines to work as all of them finished working from home before and after the implementation of With Corona.

 

In the case of Hanmi Pharmaceutical, it is discussing whether to reapply telecommuting due to the re-proliferation of COVID-19.

 

The results of the discussion are expected to come out as early as today (7th).

 

Hanmi Pharmaceutical, like Yuhan Corporation, has terminated telecommuting since last month.

 

Separately, all year-end official events will be canceled or replaced online.

 

In the case of other private gatherings, executives and employees were informed to follow government guidelines.

 

Most of the other domestic pharmaceutical companies, including Chong Kun Dang, Dong-A ST, and Ildong Pharmaceutical, have a similar rules.

 

It is said that guidelines have been issued to replace year-end events such as year-end parties and closing ceremonies online only if necessary, and to refrain from small workshops and dinners by department.

 

An official from a large pharmaceutical company said, "There are no separate guidelines.

 

However, there is an atmosphere among most employees to refrain from private gatherings such as year-end dinners, he said.

 

Another pharmaceutical company official said, "We did not prepare an official event at the end of the year.

 

It will also be replaced online so that workshops that were planned on a small scale by each department can be used, he said.

 

Multinational pharmaceutical companies maintain quarantine guidelines such as telecommuting, official meetings, and refraining from outside events regardless of the implementation of With Corona.

 

Pfizer Pharmaceutical Korea, Novartis Korea, and AstraZeneca Korea plan to continue working from home, which have been doing since the beginning of COVID-19.

 

Likewise, year-end workshops and seminars are held non-face-to-face.

 

It is recommended to refrain from official gatherings or outside events as before.

 

Since the implementation of With Corona, MSD has switched to allowing all employees to work from home twice a week.

 

Since the government's quarantine guidelines have been strengthened, it has been recommended that in-office workers can voluntarily decide to work, and outside workers should refrain from visiting except in unavoidable cases.